20240010636. HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE simplified abstract (Samsung Electronics Co., Ltd.)

HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE

Organization Name

Samsung Electronics Co., Ltd.

Inventor(s)

Yeon Sook Chung of Suwon-si (KR)

Eunjeong Choi of Suwon-si (KR)

Eunhye An of Osan-si (KR)

Heechoon Ahn of Seoul (KR)

Giwook Kang of Yongin-si (KR)

Eunsuk Kwon of Suwon-si (KR)

Yeseul Lee of Hwaseong-si (KR)

Dongjin Jang of Suwon-si (KR)

Seowon Cho of Hwaseong-si (KR)

Yongsik Jung of Suwon-si (KR)

Hwang Suk Kim of Suwon-si, Gyeonggi-do (KR)

Hyeonho Choi of Suwon-si (KR)

Byoungki Choi of Suwon-si (KR)

HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240010636 titled 'HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE

Simplified Explanation

The abstract of the patent application describes a group represented by formula a, wherein various integers and variables are defined. The heterocyclic compound represented by formula 1 contains at least one deuterium and has specific binding sites and substituents.

• The patent application relates to a group represented by formula a and a heterocyclic compound represented by formula 1.
• The group represented by formula a has specific values for k1, n1, n2, d1, d2, d3, d4, d5, d6, and d7.
• The heterocyclic compound represented by formula 1 contains at least one deuterium and has specific binding sites indicated by * and defined substituents.

Potential Applications of this Technology:

• Pharmaceutical industry: The heterocyclic compound with deuterium substitution may have potential applications in drug discovery and development.
• Chemical synthesis: The defined group and compound can be used in the synthesis of various organic compounds and materials.

Problems Solved by this Technology:

• Isotope labeling: The incorporation of deuterium in the heterocyclic compound allows for isotopic labeling, which can be useful in studying reaction mechanisms and metabolic pathways.
• Selective binding: The specific binding sites indicated in the compound's structure can enable selective interactions with target molecules, potentially leading to the development of new therapeutics or catalysts.

Benefits of this Technology:

• Enhanced stability: Deuterium substitution can improve the stability and bioavailability of the heterocyclic compound, making it more suitable for pharmaceutical applications.
• Selective reactivity: The defined substituents and binding sites provide control over the compound's reactivity, allowing for targeted modifications and functionalizations.

Note: The provided output is in plain text format. To convert it to mediawiki markup, you can add appropriate formatting tags.

Original Abstract Submitted

wherein eis a group represented by formula a; k1 is an integer from 1 to 5; n1 is 2 or 3; n2 is an integer from 0 to 3; d1, d2, d3, d5, and d6 are each independently an integer from 0 to 4; d4 is an integer from 0 to 3; d7 is an integer from 0 to 5; wherein the heterocyclic compound represented by formula 1 comprises at least one deuterium; * indicates a binding site to an adjacent atom; and the remaining substituents are as defined herein.